Find the right fit for you - faster
Get tailored insights about working at Cellarity in one quick step.
Cellarity Snapshot
Cellarity’s mission is to fundamentally redesign the way drugs are created for the sake of bringing new hope to patients.
By shifting the focus from a single target to the underlying cellular dysfunction, we unravel the complexity of disease biology and create medicines that were never before possible. The company has developed unique capabilities that link biology and chemistry with high dimensional -omic data from which we design medicines against the cellular signature of disease. The Cellarity platform allows us to uncover new biology in diseases even in the absence of known causal targets. The company has drug discovery programs underway in several disease areas, including metabolic disease, hematology, and immunology. Cellarity recently completed a Series C financing, and has raised a total of $274M from all funding rounds to date, with contributions from world-renowned investors alongside Flagship Pioneering who created the company. Cellarity’s goal is to grow into a fully integrated next generation Biotech company driving a new age in drug creation.
